End Point Management (EPM) in Clinically Significant Diabetic Macular Edema (CSME)

被引：0
作者：
Shekoh, Noor-Ul-Ain [1 ]
Fatima, Tooba [2 ]
Shekoh, Quratulain [3 ]
Gonzalez, Victor H. [1 ]
机构：
[1] Valley Retina Inst, Mcallen, TX USA
[2] Jinnah Sindh Med Univ, Karachi, Sindh, Pakistan
[3] Univ Houston, Houston, TX USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2022年 / 63卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3742-F0163
引用
收藏
页数：3
相关论文
共 50 条
[21]   Optical coherence tomography titrated photocoagulation in diabetic clinically significant macular edema [J].
Das, T ;
Simanjuntak, G ;
Sumasri, K .
MACULA: DIAGNOSIS, TREATMENT AND FUTURE TRENDS, 2004, :185-194
[22]   Diurnal variation in clinically significant diabetic macular edema measured by the stratus OCT [J].
Polito, A ;
Del Borrello, M ;
Polini, G ;
Furlan, F ;
Isola, M ;
Bandello, F .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2006, 26 (01) :14-20
[23]   VISUAL-FIELD IN TREATMENT CONTROL OF CLINICALLY SIGNIFICANT DIABETIC MACULAR EDEMA [J].
ROLDANPALLARES, M ;
ELBROMBOLY, TH ;
VILARMASEDA, NF .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) :S482-S482
[24]   MICROANEURYSM TURNOVER PREDICTS RISK OF DEVELOPMENT OF CLINICALLY SIGNIFICANT DIABETIC MACULAR EDEMA [J].
Ribeiro, L. ;
Nunes, S. ;
Cunha-Vaz, J. .
EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2013, 23 (03) :448-448
[25]   F/A and ICG guided, sub-threshold, reduced fluence Focal Laser Photocoagulation Treatment (SRFLPT) in patients with Diabetic Clinically Significant Macular Edema (CSME) [J].
Papastergiou, Georgios ;
El-Jabali, Fayssal ;
Waite, Karl ;
Bennett, Michael .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
[26]   Role of brimonidine in the treatment of clinically significant macular edema with ischemic changes in diabetic maculopathy [J].
Parul Chawla Gupta ;
Sunandan Sood ;
Subina Narang ;
Parul Ichhpujani .
International Ophthalmology, 2014, 34 :787-792
[27]   Use of a scanning laser topographic ophthalmoscope in evaluation of clinically significant diabetic macular edema [J].
Tanguilig, GG ;
Magbalon, MJ ;
Heroux, MA ;
Harrell, MD ;
Steidl, SM .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) :1598-1598
[28]   Role of brimonidine in the treatment of clinically significant macular edema with ischemic changes in diabetic maculopathy [J].
Gupta, Parul Chawla ;
Sood, Sunandan ;
Narang, Subina ;
Ichhpujani, Parul .
INTERNATIONAL OPHTHALMOLOGY, 2014, 34 (04) :787-792
[29]   COMPARISON OF STEREOSCOPIC AND NONSTEREOSCOPIC FUNDUS PHOTOGRAPHS FOR EVALUATION OF DIABETIC CLINICALLY SIGNIFICANT MACULAR EDEMA [J].
PATEL, SC ;
WEINBERG, DV ;
BAUMAN, WC ;
SANNI, N ;
PAVELOFF, M .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1994, 35 (04) :1396-1396
[30]   Microaneurysm Turnover and Phenotypes of Nonproliferative Diabetic Retinopathy Progression to Clinically Significant Macular Edema [J].
Cunha-Vaz, J. .
INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY AND THERAPEUTICS, 2013, :51-54
12345